Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B. Leighton
PDH Kinase Inhibitors: A Novel Therapy for Type II Diabetes?
Biochemical Society Transactions
Biochemistry
AZD7545, a Novel Inhibitor of Pyruvate Dehydrogenase Kinase 2 (PDHK2), Activates Pyruvate Dehydrogenase in Vivo and Improves Blood Glucose Control in Obese (Fa/Fa) Zucker Rats
Biochemical Society Transactions
Biochemistry
Related publications
Tyrosine Kinase Inhibitors for Diabetes
Science-Business eXchange
Affinity-Based Probes Based on Type II Kinase Inhibitors
Journal of the American Chemical Society
Biochemistry
Colloid
Catalysis
Chemistry
Surface Chemistry
Gene Therapy for Type 1 Diabetes: A Novel Approach for Targeted Treatment of Autoimmunity
Journal of Clinical Investigation
Medicine
Dihydropyrrolopyrazole Transforming Growth Factor-B Type I Receptor Kinase Domain Inhibitors: A Novel Benzimidazole Series With Selectivity Versus Transforming Growth Factor-B Type II Receptor Kinase and Mixed Lineage Kinase-7
Novel Thioredoxin Inhibitors for Breast Cancer Therapy
Personalized Therapy of Tyrosine Kinase Inhibitors
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Fetuin-A: A Biomarker for Type II Diabetes Mellitus
International Journal of Biomedical Materials Research
Cyclophilin Inhibitors as a Novel HCV Therapy
Viruses
Virology
Infectious Diseases
Designing Visfatin Inhibitors to Limit Its Insulin Mimcy and Type II Diabetes.